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Determination of Numbers of Lead-Exposed
Women of Childbearing Age and Pregnant
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Report to the U.S. Congress on
Childhood Lead Poisoning
by Annemarie F. Crocetti* Paul Mushak,t and
Joel Schwartz'
In a Congressionally mandated study carried out under the aegis ofthe U.S. Agency for Toxic Substances
andDisease Registry(AISDR) and summarized in this article, the authorshaveprovidedestimatesofthe numbers
ofAmerican women ofchildbearing age and the numbers ofAmerican pregnant women whose lead exposure
is sufficiently elevated to pose an intrauterine toxicity risk. Exposures associated with such risk were defined
as blood lead (PbB) levels > 10, > 15, > 20, and > 25 ig/dL. Using PbB prevalence projection techniques
based on the Second National Health and Nutrition Examination Survey (NHANES II), we first generated
projected 1984 prevalences of these PbB levels in white and black women of childbearing age, ages 15 to 19
and 20 to 44. White women in the two age bands had rates ofPbBs > 10 ig/dL of9.2 and 9.7%, respectively.
Forblackwomen, thecorresponding rates were 8.2 and 19.7%, respectively. Combiningtheserates with standard
metropolitan statistical areas (SMSAs) based 1980 Census andotherpopulationenumerations show, forexample,
that 4.4 million U.S. women of childbearing age are estimated to have had PbBs > 10 /ig/dL.
Pregnantblackandwhite women inU.S. SMSAs areapproximately9%ooftheU.S. black and whitechildbearing
age total, i.e., 3.6 million out ofa 41.3 million SMSA total. Ofthese, 403,200 pregnant women were estimated
to have PbB levels > 10 4g/dL. Cumulative totals ofexposed fetuses with persisting long-term exposure will
be greater, in as much as a given fetus is never counted more than once in this type ofsurvey. Over 10 years,
the number would be over 4 million fetuses at elevated risk of health effects.
Introduction
In pregnant women, lead readily crosses the placental
barrier early in gestation (1-4). In utero exposure therefore
occurs at periods ofembryological development when impor-
tant organ and system elaboration can be affected adversely
bylead uptake. Severe, clinically manifested in utero effects
hadbeen known for many years (4) in pregnant women who
were occupationally exposed. Currently, it is the intrauterine
effects oflow-level lead exposure that command the attention
of the public health communities (4-8).
Two important points can be noted concerning in utero
lead exposure: in utero impact canbe irreversible based on
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current data, and the adverse impacts ofmaternal bloodlead
have been found atlowlevels, as low as 10/xg/dL and some-
whatlower, based on current studies. While pregnantwomen
are recognized as a high risk population segment because
of intrauterine exposure of the fetus (4), they were not
specifically identified for consideration in recent Federal
legislation mandating a report to Congress on U.S. childhood
lead poisoning. This report, prepared under the sponsorship
of the Agency for Toxic Substances and Disease Registry
(ATSDR), did take account ofthe fact thatintrauterine lead
exposure is a component in developmental lead toxicity, and
the ensuing assessment is the basis of this article.
In this article, the authors ofthis section ofthe Congres-
sional report analyze the quantitative aspects ofthe impact
oflow-level lead exposure on the developing fetus (9). We
used various blood lead (PbB) toxicity criterion levels and
1980 Census data to arrive at relevantly stratified U.S. female
population exposure numbers. Risk assessment factors in
the current analyses imply that every pregnancy potentially
represents a fetus at risk if the mother has a blood leadCROCETTI ET AL.
level of 101tg/dL orhigher. Since the composition ofpreg-
nant women is not a predictable segment of the popula-
tion, women of childbearing age are also examined in this
analysis.
Strategies and Methods
We have firstestablished numbers ofwomenofchildbear-
ing age and pregnant women by two race and two age
groups. We decided to examine women residing in stan-
dard metropolitan statistical areas (SMSAs) and ofchildbear-
ing age for 1984, a relatively recent date that matches our
examination ofyoung children, and for which relevant PbB
prevalences could be estimated. In addition, estimates of
pregnant women for that year were obtained to illustrate
the extent of risk to fetuses at any given time.
The following methodological steps established the re-
quired information for the populations and estimates ofprev-
alences of blood lead levels among them: a) U.S. Census
Bureau population projections for 1984 were used, as well
as 1980 census data on residential distribution, to estimate
the number of white and black women aged 15 to 19 and
20 to 44 who live in SMSAs. b) From the Division ofVital
Statistics ofthe National Center for Health Statistics data,
the numbers oflive births occurring in SMSAs in 1984 were
counted and fetal deaths for 1984 apportioned to SMSAs.
Data for legal abortions for 1984 were not yet available,
and other data from CDC (10,11) were used. From these
three sources, the total number ofpregnancies regardless
ofoutcome were estimated for the four race/age strata of
women in SMSAs. c) Estimates ofprevalences ofPbB levels
of interest in pregnant women for 1984 were provided by
the U.S. EPA Office of Policy Analysis, Washington, DC,
by the same methodology as cited to project PbB level
prevalences in young children for effects of gasoline lead
phase-down action (12). These projections used baseline
prevalences ofPbB levels found in the 1976-1980 Second
U.S. National Health and Nutrition Examination Survey
(NHANES II) (13).
Specifically, the same technique of logistic regression
analysis was carried out as before and as described in detail
in Appendix G of the Congressional report (14) and in an
earlier EPA impact analysis report directed to regulatory
initiatives forphase-down oflead in gasoline (12). The PbB
criterion values of concern were >10, >15, >20, and
>25Ag/dL. Projected estimates ofprevalences for use in
1984 were necessitated by the observed declines in gasoline
lead occurring in PbB during the time of the NHANES II
survey period to more recent years.
With respect to the methodological approaches employed
in this chapter, severalpoints require discussion. The selec-
tion of the two age categories for women of childbearing
age is based on the fact that women below 20 years ofage
tend to have ahigh risk ofpregnancies with poor outcomes
in general and without specific reference to the blood lead
status of the mother (15). Further, the NHANES II data
for women ofchildbearing age indicate not only that blood
lead levels showed variations for white and black women,
but that women of either race showed variation by age.
We therefore examined four categories in this population:
white, aged 15 to 19; white, aged 20 to 44; black, aged
15 to 19; and black, aged 20 to 44.
The attemptto estimate all pregnancies regardless ofout-
come is based on the recognition that the various outcomes
are not intrinsically statistically relevant to the risk offetal
exposure to maternalbloodleadlevels. Legalabortions were
included because data are available for the extent of this
outcome; fetal wastage, that is, spontaneous abortions
before 20 weeks ofgestation, were not considered because
no data exist.
The estimate ofwomenofchildbearing age includes some
proportion ofwomen who will never experience pregnancy.
We know of no method to estimate this proportion.
However, we believe that consideration of the number of
pregnancies in a given year provides some measure of-
assessing the size of the surrogate population at risk.
The Census Bureau projects future population using three
methods of calculation. The middle series projections for
1984 were used (16), which provide estimates by age, sex,
and race, and have a 12% error for the 1984 projections
(16). These are projections for the entire country, and to
establish the proportion ofwomenlivingin SMSAs, the 1980
residential distribution was applied to the projected 1984
figures for the four categories of women (17).
The data available for 1984 live births consisted of com-
puter output (Division of Vital Statistics, National Center
for Health Statistics) from which we had established the
number of live births for each SMSA as defined in 1980.
The births were identified by race, but not by age of the
mother. We used the latest available data, 1981, for distribu-
tion of live births for each race by the mother's age (18)
to allocate the 1984 live births ofall SMSAs. The fetal deaths
for 1984 were provided by the Division of Vital Statistics
and were allocated the maternal age categories within race
groups by applying published information for 1981 (19).
Information for 1984 legal abortions is not yet available,
and we used 1983 data. Examining the data available for the
years 1971 through 1983, a peak in rates appears in 1980
and since then rates have declinedvery gradually. Since the
number ofwomen ofchildbearing age has increased steadily,
the actual number of legal abortions continued to increase
through 1982. In 1983, not only the rates but the actual
number ofabortions showed a decrease. Since the decrease
ofthe rates is quite gradual and the actual number for 1983
below those for 1980, 1981, and 1982, employing the 1983
rates for 1984 seemed conservative.
CDC data (11) concerning legal abortions provides ratios
of abortions to live births (per 1000 live births) and a rate
of abortions (per 1000 women aged 15 to 44) for each of
the states and the District ofColumbia. A national ratio and
rate are also presented. Information on the distribution of
abortions by age and race are also provided, but these data
are not available on a state basis.
We used two methods of estimating 1984 abortions for
the SMSAs and used the result that provided the smaller
numbers. An earlier, discarded method consisted ofapply-
ing the ratio for each state to the number oflive births that
had occurred in SMSAs in that state in 1984. The sum of
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Table 1. Estimated percentages of women of childbearing
age exceeding selected PbB values by race and age
for populations in all SMSAs, 1984.a
Age, PbB, t4g/dL
Race years >10 >15 >20 >25
White 15-19 9.2 0.5 0.1 0.03
20-44 9.7 1.8 0.4 0.1
Black 15-19 8.2 1.3 0.2 0.05
20-44 19.7 3.7 0.7 0.2
aEstimates of prevalances computed by EPA's Office of Policy Analysis,
Washington, DC, using methods in Appendix G (14).
these calculations was then proportioned into race and age
categories according to data available for 1983. The alter-
nate method consisted ofapplying the rate (per 1000 women
15 to 44) to the 1984 population estimates obtained from
the Census Bureau projections for 1984. The resulting total
was allocated to the race/age categories according to 1983
abortion data. A difference of about 3% was observed be-
tween the two methods, and the smaller total was selected
for inclusion.
Results and Discussion
The projected prevalence rates for the four strata of
women ofchildbearing age and pregnant women are shown
in Table 1 for the four PbB criterion levels. It should be
borne in mind that the criterion value of 10 1zg/dL lies in
avery narrow portion ofthe PbB range. Certain prevalence
values in the table, particularly that for the older group of
black women, appear to be unusually high when compared
to the other prevalences. However, because ofthe narrow-
ness of the PbB range at 10 Ag/dL, rather small changes
in the mean PbB values will account for rather large differ-
ences in prevalences.
The pattern of increasing group values with increasing
age, discussed in Chapter 10 ofEPA's lead criteria document
(4), can be seen in the means for each of the two racial
groups. U.S. EPA (4) reports an increase of approximately
1 Itg for each decade of age increase. The differences in
geometric means foryoung and older women in each ofthe
racial groups amounts to about 2 Ag/dL.
The prevalence estimates were then applied to the esti-
mated population strata and the findings are presented in
Table 2. Census projections for 1984 and demographic dis-
tributions for 1980 were used to estimate the 41,300,000
white and black women of childbearing age who lived in
SMSAs in 1984. The estimated numbers of these women
in the fourrace/age categories above the selected PbB levels
were >10plg/dL4,460,600; >15 ,lg/dL 761,400; >20 ig/dL
161,600; and >25 1zg/dL 41,800.
The estimating procedure outlined above yielded a total
of 3,595,000 pregnant women for 1984. Of these, 403,200
are estimated to have a PbB level above 10 Ag/dL, 69,400
above 15 /tg/dL, 14,500 above 20 ,ug/dL, and 3,800 above
25 ,ug/dL.
Estimated prevalences of PbB at these selected levels
for 1984 are lower than those obtained from the survey data
Table 2. Estimated number of women of childbearing
age and estimated number of pregnant women and
projected numbers above four selected PbB criterion
values by race and age in all SMSAs, 1984.
PbB, Itg/dL
Race/age, years Number >10 >15 >20 >25
Women in SMSAsa
White 15-19 5,478,000 504,000 27,400 5,500 1,600
20-44 29,740,000 2,884,800 535,300 119,000 29,700
Black 15-19 1,098,000 90,000 14,300 2,200 500
20-44 4,984,000 981,800 184,400 34,900 10,000
Total 41,300,000 4,460,600 761,400 161,600 41,800
Pregnant women in SMSAsa
White 15-19 433,000 39,800 2 ,200 400 100
20-44 2,380,000 230,900 42,800 9,500 2,400
Black 15-19 187,000 15,300 2,400 400 100
20-44 595,000 117,200 22,000 4,200 1,200
Totalb 3,595,000 403,200 69,400 14,500 3,800
aMethod of calculating explained in text.
bTotals by addition, not estimated.
collected during 1976 to 1980 (13) which is attributable to
the reduction in ambient air lead pollution (4). However it
should be noted that women have a smaller uptake of air-
borne lead than children on a body weight basis. Unlike
children, women obtain the major portion ofthe total body
burden of lead from food and water; a smaller fraction is
derived from paint dust and soil lead relative to that of
preschool children. Lead in the food of adults, providing
exposure for teenage and adult women, may notbe reduced
by the same amounts as for infants and toddlers (14),
although reductions are certainly occurring across all age
groups.
These projections for women should be viewed in light
ofthe methodological variables that will contribute to both
overestimation and underestimation. The logistic regression
analysis accounts for the declines in women's PbB due to
the phase-down of lead in gasoline but does not account
for the reductions oflead in food over this time span. This
would result in an overestimation.
The original NHANES II survey did not include enough
women of "other race" to establish statistically reliable
prevalences ofPbB levels. Consequently this entire popula-
tion segment is excluded from the estimates presented,
which are restricted to white and black women. Women of
other race constitute sizable segments ofthe female popula-
tions in SMSAs in the West and Southwest ofthe country.
Finally, the women not residing in SMSAs, about20%, were
omitted entirely from the calculations presented and result
in significant underestimations.
Women of childbearing age represent about 45% of the
total female population. The prevalence rates for PbB levels
significant to the impairment of healthy fetal development
equate to about 4,460,600 women in the urban population.
At any given time almost 9% are pregnant, and in a given
year about400,000 pregnancies are at risk for adverse health
effects from maternal lead (>10 1tg/dL PbB).
Since pregnant women within this population segment are
continuously changing and not readily identifiable, the same
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quantitative problem recurs until abatement reduces the lead
in the environment of these women. In other words, no
fixed, identifiable group ofindividuals has a one-time expo-
sure risk. Over a 10-yearperiod, forexample, the cumulative
number of individual fetuses at risk will be 10 times that
of a single-year tally in the absence of steps to abate the
levels of lead exposure producing the current numbers in
Table 2. This amounts to over4 million fetuses. In 50 years,
this cumulative tally is about 20 million fetuses.
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